A similar trend was observed in thyroid pathology where increased CYP24A1 expression was found in follicular adenomas, while in differentiated thyroid cancers its level decreased, being comparable with normal tissues [47]. This evidence concerns the gene CYP24A1 and thyroid gland carcinoma.